Aptevo Therapeutics (NASDAQ:APVO) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Aptevo Therapeutics (APVO) operate in?

Aptevo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Aptevo Therapeutics Stock (NASDAQ: APVO) stock price, news, charts, stock research, profile.

Open	$0.42
Close	$0.31
Volume / Avg.	2.52M / 856.97K
Day Range	0.30 - 0.43
52 Wk Range	0.48 - 80.96
Market Cap	$1.30M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	21
Short Interest	0.52%
Days to Cover	1

Recent News

Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E

Investors often opt for the stock-picking approach that involves stocks with a low price-to-earnings (P/E) ratio. This strategy is based on the notion that the lower the P/E ratio is, the higher the stock value. The reasoning behind this is simple — when a stock's current market price does not adequately reflect its higher earnings, it suggests potential for growth.

Zacks

Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Nasdaq Jumps 250 Points; Crude Oil Down 1%

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The Dow traded up 0.18% to 38,532.50 while the NASDAQ rose 1.63% to 16,433.83. The S&P 500 also rose, gaining, 0.83% to 5,203.26.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Aptevo Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Aptevo Therapeutics (APVO) stock?

You can purchase shares of Aptevo Therapeutics (NASDAQ:APVO) through any online brokerage.

View our list of the best stock brokerages

Who are Aptevo Therapeutics (APVO) competitors?

Other companies in Aptevo Therapeutics’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Alzamend Neuro (NASDAQ:ALZN), Exicure (NASDAQ:XCUR), Tharimmune (NASDAQ:THAR) and Dermata Therapeutics (NASDAQ:DRMA).

What is the target price for Aptevo Therapeutics (APVO) stock?

There is no analysis for Aptevo Therapeutics.

What is the forecast for Aptevo Therapeutics (APVO) stock?

Aptevo Therapeutics has a consensus price target of $20.00.

Current stock price for Aptevo Therapeutics (APVO)?

The stock price for Aptevo Therapeutics (NASDAQ: APVO) is $0.319 last updated June 28, 2024 at 7:58 PM EDT.

Does Aptevo Therapeutics (APVO) pay a dividend?

There are no upcoming dividends for Aptevo Therapeutics.

When is Aptevo Therapeutics (NASDAQ:APVO) reporting earnings?

Aptevo Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Is Aptevo Therapeutics (APVO) going to split?

There is no upcoming split for Aptevo Therapeutics.

What sector and industry does Aptevo Therapeutics (APVO) operate in?

Aptevo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Aptevo Therapeutics

Aptevo Therapeutics (APVO) Forecast